Skip to main content

Table 1 Basic characteristics of included studies

From: Impact of resistance exercise on patients with chronic kidney disease

Author

Year

Stage

N

Age(I)

F/M(I)

BMI(I)

Age(C)

F/M(C)

BMI(C)

Duration

Diabetes

Renovascular

Glomerulonephritis

Polycystic kidney disease

other

Hugo

2021

2

60

58 ± 9

18/12

NA

57 ± 6

11/19

NA

6 months

NA

NA

NA

NA

NA

Erin

2015

3,4

72

60.2 ± 9.7

12/24

NA

62.0 ± 8.4

15/21

NA

12 months

20

11

21

3

17

Thaís

2022

2

31

57.94 ± 2.74

NA

26.64 ± 3.47

58.07 ± 5.22

NA

26.84 ± 1.95

22 weeks

NA

NA

NA

NA

NA

Sandra

2016

NA

13

71.5(58.5–87.2)

3/3

28.5(21.1–35.8)

76.0(59.0–83.0)

3/4

28.4(20.8–35.2)

8 weeks

NA

NA

NA

NA

NA

Abreu

2017

NA

44

45.7 ± 15.2

14/11

23.9 ± 4.7

42.5 ± 13.5

12/7

24.4 ± 4.8

6 months

NA

NA

NA

NA

NA

Barcellos

2018

2,3,4

150

65.0(1.2)

49/27

29.7(0.7)

65.1(1.3)

46/28

30.1(0.6)

16 weeks

NA

NA

NA

NA

NA

Carmen

2004

NA

26

65 ± 9

6/8

29.3 ± 6.6

64 ± 12

3/9

26.8 ± 2.7

12 weeks

NA

NA

NA

NA

NA

Kiyotaka

2021

4

46

72(69–79)

6/17

24.7 ± 4.6

76(69–78)

7/16

23.0 ± 4.3

6 months

14

12

NA

NA

NA

David J

2016

2,4

36

65.4 ± 8.7

0/18

36.2 ± 4.8

66.6 ± 7.5

0/18

37.4 ± 4.2

12 weeks

36

NA

NA

NA

NA

Samuel

2015

NA

46

58.0(8.0)

9/16

34.9(8.0)

57.1(9.0)

7/14

36.5(8.9)

14 weeks

2

NA

NA

NA

44

Jie

2011

NA

32

46.5 ± 12.1

6/9

27.5 ± 6.3

40.2 ± 13.5

5/12

29.1 ± 6.4

6 months

6

NA

NA

NA

26

Bobby

2007

NA

49

60.0 ± 15.3

7/17

74.9 ± 19.5

65.0 ± 12.9

8/17

76.5 ± 17.4

12 weeks

9

4

12

4

20

Ma

2016

NA

61

28.5(23-46.5)

16/14

21.8 ± 3.1

29(19–38)

12/19

21.1 ± 2.7

12 weeks

2

NA

NA

NA

NA

Song

2012

NA

40

52.1 ± 12.4

12/8

NA

54.6 ± 10.1

8/12

NA

12 weeks

22

NA

NA

NA

NA

Koji

2017

3,4

28

69.0 ± 6.8

NA

24.4 ± 3.5

67.8 ± 6.9

NA

23.0 ± 2.5

12 months

2

NA

8

1

17

Kumi

2021

NA

53

66.19 ± 13.05

6/20

22.52 ± 3.94

64.00 ± 12.95

6/21

23.30 ± 4.55

6 months

15

NA

16

NA

22

  1. N: the total number of participants in the resistance exercise and control groups; Age(I): Age of the group of CKD patients with resistance exercise; F/M(I): The ratio of female to male patients of the group of CKD patients with resistance exercise; BMI(I): BMI of the group of CKD patients with resistance exercise; Age(C): Age of the group of CKD patients without resistance exercise; F/M(C): The ratio of female to male patients of the group of CKD patients without resistance exercise; BMI(C): BMI of the group of CKD patients without resistance exercise; Duration: Duration of resistance exercise intervention